ADROVANCE (clone FOSAVANCE) INN-Alendronic acid as
Detailed information on this medicinal product is available on the website of the European Medicines. Agency http://www.ema.europa.eu. Page 15. 15. ANNEX II. A.
adrovance epar product information en
"ADROVANCE (clone FOSAVANCE) INN-Alendronic acid as
EMA/194587/2011. EMEA/H/C/000759. Résumé EPAR à l'intention du public. Adrovance acide alendronique / colécalciférol. Ce document est un résumé du rapport
adrovance epar summary public fr
Adrovance INN-alendronic acid/ colecalciferol
EMA/194587/2011. EMEA/H/C/000759. EPAR summary for the public. Adrovance alendronic acid / colecalciferol. This is a summary of the European public
adrovance epar summary public en
"ADROVANCE (clone FOSAVANCE) INN-Alendronic acid as
EMA/194587/2011. EMEA/H/C/000759. Sammanfattning av EPAR för allmänheten. Adrovance alendronsyra och kolekalciferol. Detta är en sammanfattning av det
adrovance epar summary public sv
"ADROVANCE (clone FOSAVANCE) INN-Alendronic acid as
Reproduction is authorised provided the source is acknowledged. EMA/194587/2011. EMEA/H/C/000759. EPAR kopsavilkums plašākai sabiedrībai. Adrovance.
adrovance epar summary public lv
"ADROVANCE (clone FOSAVANCE) INN-Alendronic acid as
Reproduction is authorised provided the source is acknowledged. EMA/194587/2011. EMEA/H/C/000759. Souhrn zprávy EPAR určený pro veřejnost. Adrovance.
adrovance epar summary public cs
"ADROVANCE (clone FOSAVANCE) INN-Alendronic acid as
EMA/194587/2011. EMEA/H/C/000759. Sommarju tal-EPAR għall-pubbliku. Adrovance aċidu alendroniku / colecalciferol. Dan id-dokument huwa sommarju tar-Rapport
adrovance epar summary public mt
"ADROVANCE (clone FOSAVANCE) INN-Alendronic acid as
EMA/194587/2011. EMEA/H/C/000759. EPAR santrauka plačiajai visuomenei. Adrovance alendrono rūgštis / kolekalciferolis. Šis dokumentas yra vaisto Adrovance
adrovance epar summary public lt
"ADROVANCE (clone FOSAVANCE) INN-Alendronic acid as
E-mail info@ema.europa.eu Website www.ema.europa.eu tener niveles bajos de vitamina D. Adrovance 70 mg/5.600 UI está indicado para su uso en pacientes.
adrovance epar summary public es
ADROVANCE (clone FOSAVANCE) INN-Alendronic acid as
ADROVANCE est indiqué dans le traitement de l'ostéoporose post-ménopausique chez les femmes à européenne des médicaments http://www.ema.europa.eu.
adrovance epar product information fr